Dapiglutide
DREAM
Zealand Pharma · Phase 2 · Active, not recruiting · Enrollment 54
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Placebo (4 mg and 6 mg) | n/r | n/r | n/r | n/r |
| 4 mg dapiglutide | n/r | n/r | n/r | n/r |
| 6 mg dapiglutide | n/r | n/r | n/r | n/r |
Not shown
- Placebo (4 mg and 6 mg): endpoint not reported
- 4 mg dapiglutide: endpoint not reported
- 6 mg dapiglutide: endpoint not reported